We are live on
!
Find out more
NR
Newfound Research Portfolio holdings
AUM
$40.8M
Turnover
15.49%
1-Year Est. Return
12.42%
This Fund
S&P 500
This Quarter
Est. Return
+4.56%
1 Year Est. Return
-12.42%
3 Year Est. Return
+54.59%
5 Year Est. Return
+89.01%
10 Year Est. Return
–
AUM
$43.2M
AUM Growth
+$4.33M
(+11%)
Cap. Flow
+$2.88M
Cap. Flow
% of AUM
6.66%
Top 10 Holdings %
Top 10 Hldgs %
72.22%
Holding
159
New
33
Increased
13
Reduced
81
Closed
32
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity Low Volatility Factor ETF
FDLO
|
+$1.17M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$1.16M |
| 3 |
Fidelity Quality Factor ETF
FQAL
|
+$1.16M |
| 4 |
JPMorgan US Quality Factor ETF
JQUA
|
+$1.16M |
| 5 |
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
|
+$1.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan US Momentum Factor ETF
JMOM
|
+$929K |
| 2 |
Fidelity Momentum Factor ETF
FDMO
|
+$926K |
| 3 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$866K |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$146K |
| 5 |
Take-Two Interactive
TTWO
|
+$145K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.38% |
| 2 | Healthcare | 4.32% |
| 3 | Technology | 3.87% |
| 4 | Industrials | 2.65% |
| 5 | Consumer Staples | 2.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Procter & Gamble
PG
$365B
| $78K | 0.18% |
575
-319
| -36% | -$41.6K |
2020 Q3
2 quarters
|
|
52
Sherwin-Williams
SHW
$81.8B
| $78K | 0.18% |
318
+75
| +31% | +$17.9K |
2020 Q4
1 quarter
|
|
53
Steris
STE
$21.9B
| $78K | 0.18% |
408
-279
| -41% | -$51.8K |
2020 Q3
2 quarters
|
|
54
Visa
V
$750B
| $78K | 0.18% |
368
-199
| -35% | -$41.9K |
2020 Q3
2 quarters
|
|
55
Yum China
YUMC
$15.1B
| $78K | 0.18% |
1,325
-841
| -39% | -$50.3K |
2020 Q3
2 quarters
|
|
56
Edwards Lifesciences
EW
$50.8B
| $77K | 0.18% |
926
-550
| -37% | -$46.5K |
2020 Q3
2 quarters
|
|
57
W.W. Grainger
GWW
$62.7B
| $77K | 0.18% |
193
-12
| -6% | -$4.64K |
2020 Q4
1 quarter
|
|
58
VeriSign
VRSN
$27.5B
| $77K | 0.18% |
388
-178
| -31% | -$35K |
2020 Q3
2 quarters
|
|
59
Clorox
CLX
$10.4B
| $76K | 0.18% |
392
+216
| +123% | +$41.6K |
2020 Q3
2 quarters
|
|
60
DELISTED
Electronic Arts
EA
| $76K | 0.18% |
563
-30
| -5% | -$4.16K |
2020 Q3
2 quarters
|
|
61
HEICO Corp
HEI
$43.1B
| $76K | 0.18% |
606
-431
| -42% | -$55.4K |
2020 Q4
1 quarter
|
|
62
Vertex Pharmaceuticals
VRTX
$129B
| $76K | 0.18% |
352
+172
| +96% | +$37.8K |
2020 Q3
2 quarters
|
|
63
Colgate-Palmolive
CL
$73.9B
| $75K | 0.17% |
957
-536
| -36% | -$42K |
2020 Q3
2 quarters
|
|
64
Intuitive Surgical
ISRG
$151B
| $75K | 0.17% |
306
-186
| -38% | -$46.8K |
2020 Q3
2 quarters
|
|
65
Tyler Technologies
TYL
$14.9B
| $75K | 0.17% |
177
-28
| -14% | -$12.1K |
2020 Q3
2 quarters
|
|
66
Zoetis
ZTS
$32.4B
| $75K | 0.17% |
478
-243
| -34% | -$38.5K |
2020 Q3
2 quarters
|
|
67
DELISTED
Ansys
ANSS
| $74K | 0.17% |
+218
| New | +$77.4K |
2021 Q1
0 quarters
|
|
68
Incyte
INCY
$23B
| $74K | 0.17% |
905
-353
| -28% | -$30.1K |
2020 Q3
2 quarters
|
|
|
CERN
69
DELISTED
Cerner Corp
CERN
| $74K | 0.17% |
1,028
-593
| -37% | -$44.6K |
2020 Q3
2 quarters
|
|
70
ResMed
RMD
$34.1B
| $73K | 0.17% |
378
-20
| -5% | -$4.01K |
2020 Q3
2 quarters
|
|
71
Verisk Analytics
VRSK
$24.4B
| $73K | 0.17% |
412
-199
| -33% | -$36.4K |
2020 Q3
2 quarters
|
|
72
Regeneron Pharmaceuticals
REGN
$82B
| $72K | 0.17% |
+152
| New | +$74K |
2021 Q1
0 quarters
|
|
73
Brown-Forman Class B
BF.B
$13.1B
| $71K | 0.16% |
1,035
-552
| -35% | -$40.4K |
2020 Q3
2 quarters
|
|
74
Estee Lauder
EL
$38.8B
| $69K | 0.16% |
238
-290
| -55% | -$79.4K |
2020 Q4
1 quarter
|
|
75
IDEX
IEX
$17.4B
| $69K | 0.16% |
328
-314
| -49% | -$62.3K |
2020 Q3
2 quarters
|
|
Similar funds
AM
PSCM
HLC
LCM
MCMI
OMS
SEM
PIM
Newfound Research's Q1 2021 Portfolio in Review
As of Q1 2021, Newfound Research held 159 positions worth $43.2M, up 11% from $38.9M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Newfound Research deployed $2.88M of net new capital in Q1 2021, opening 33 new positions and adding to 13 existing holdings. Its largest new stake was Fidelity Low Volatility Factor ETF: 27,216 shares worth $1.19M.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 69% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was JPMorgan US Momentum Factor ETF, an estimated $929K trimmed.
- Newfound Research's largest Q1 2021 buy was Fidelity Low Volatility Factor ETF: 27,216 shares worth $1.19M.
- Newfound Research added most to Vanguard US Momentum Factor ETF in Q1 2021, an estimated $984K increase.
- Newfound Research's biggest Q1 2021 reduction was JPMorgan US Momentum Factor ETF, cutting an estimated $929K.
- Newfound Research fully exited Xilinx Inc in Q1 2021, selling an estimated $146K.
- Newfound Research's ten largest holdings make up 72% of its $43.2M portfolio in Q1 2021.
- Newfound Research opened 33 new positions and closed 32 in Q1 2021.
- Newfound Research's portfolio value rose 11% quarter-over-quarter to $43.2M.
Based on Newfound Research's 13F filing for Q1 2021, filed 28 Apr 2021.